Unjha Formulations Valuation

Q: What is the Fair Price of 531762 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

531762 (₹27.4) is trading below our estimate of [[fair value]] (₹400.55)

Is 531762 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 531762 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 531762 (₹27.4) is trading below our estimate of fair value (₹400.55)

Significantly Below Fair Value: 531762 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 531762?

Key metric: As 531762 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 531762. This is calculated by dividing 531762's market cap by their current earnings.
What is 531762's PE Ratio?
PE Ratio	15.3x
Earnings	₹8.02m
Market Cap	₹125.63m

531762 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.6x
Enterprise Value/EBITDA	10.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 531762's PE Ratio compare to its peers?

The above table shows the PE ratio for 531762 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	55.4x
539680 Ganga Pharmaceuticals	133.2x	n/a	₹72.5m
WALPAR Walpar Nutritions	16.9x	n/a	₹399.6m
542248 Deccan Health Care	34.9x	n/a	₹553.4m
524703 Sandu Pharmaceuticals	36.5x	n/a	₹555.7m
531762 Unjha Formulations	15.3x	n/a	₹125.6m

Price-To-Earnings vs Peers: 531762 is good value based on its Price-To-Earnings Ratio (15.3x) compared to the peer average (55.4x).

Price to Earnings Ratio vs Industry

How does 531762's PE Ratio compare vs other companies in the IN Personal Products Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 531762 is good value based on its Price-To-Earnings Ratio (15.3x) compared to the Asian Personal Products industry average (25.2x).

Price to Earnings Ratio vs Fair Ratio

What is 531762's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

531762 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	15.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 531762's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Hindustan Unilever

₹5.7t

A fast-moving consumer good company, manufactures and sells food, home care, personal care, and refreshment products in India and internationally.

500696

₹2,383.25

-0.2%

-5.4%

Hindustan Unilever

₹5.7t

A fast-moving consumer good company, manufactures and sells food, home care, personal care, and refreshment products in India and internationally.

HINDUNILVR

₹2,382.80

-0.3%

-5.4%

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

DABUR

₹505.75

-0.5%

-6.4%